## CTSH: Cognizant Technology Solutions Corporation - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -3.1% below STRENGTH zone (3.0-6.0%); PEG 1.50 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($78.10)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Bearish (Bullish: 0, Bearish: 5)

**1. Cognizant Technology Solutions Corp Class A Stock Price Live, Charts & News**
- Source: The Economic Times | 20251231T230742 | Somewhat-Bearish | Relevance: 100%
- This article provides live stock price data, charts, and news for Cognizant Technology Solutions Corp Class A (CTSH) on NASDAQ. It details key financial metrics, historical returns, balance sheets, income statements, and cash flow statements, offering a comprehensive overview of the company's financial health and market performance.

**2. Cognizant hit with many US class-action lawsuits after TriZetto data breach**
- Source: Business Standard | 20260102T090804 | Bearish | Relevance: 100%
- Cognizant Technology Solutions Corp is facing several class-action lawsuits in the US following a data breach at its healthcare unit, TriZetto Provider Solutions. The lawsuits allege that TriZetto failed to protect personal data and did not timely inform affected individuals about a cyberattack that potentially exposed sensitive information like social security numbers and bank details. Plaintiffs are seeking over $5 million in damages, regular security audits, and deletion of unnecessary personal data, while Cognizant states it cannot comment due to ongoing litigation.

**3. Cognizant faces class-action lawsuits after TriZetto data breach**
- Source: Communications Today | 20260102T071244 | Bearish | Relevance: 100%
- Cognizant Technology Solutions Corp is facing multiple class-action lawsuits in the US regarding an alleged data breach at its healthcare claims processing unit, TriZetto. The lawsuits claim that TriZetto failed to disclose a cyberattack in a timely manner, which allegedly went undetected or undisclosed for nearly a year, impacting personal information of at least 100 individuals. The petitioners are seeking monetary damages, attorney fees, jury trials, and court orders for regular third-party audits and data deletion.

**4. Cognizant faces lawsuits in US over TriZetto Healthcare data breach**
- Source: MSN | 20260102T050742 | Bearish | Relevance: 100%
- Cognizant is facing multiple lawsuits in the US following a data breach that affected its TriZetto Healthcare subsidiary. The lawsuits are expected to be class action suits, consolidating individual complaints into a single case, and seek compensation for the data breach. The breach reportedly impacted millions of patients whose data was stolen or lost.

**5. Cognizant faces lawsuits in US over TriZetto Healthcare data breach**
- Source: The Economic Times | 20260102T000855 | Bearish | Relevance: 100%
- Cognizant Technology Solutions Corp is facing multiple class action lawsuits in the US after its healthcare claims processing subsidiary, TriZetto Provider Solutions (TPS), experienced a major data breach. The lawsuits allege that TPS failed to adequately safeguard sensitive patient data and delayed notifying those affected after a cyberattack, which occurred around November 2024 but was not identified until October 2025. Over 100 people are believed to be impacted, with claimed damages exceeding $5 million.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | UBS | $82 | $78 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | UBS | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 26 ($0.00M) |
| Sells | 21 ($3.66M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 52.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (+0.8%)
- Blackrock Inc.: 10.5% (-0.2%)
- JPMORGAN CHASE & CO: 8.2% (+108.3%)
- State Street Corpora: 5.2% (-0.9%)
- Pzena Investment Man: 3.7% (+1.5%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-2.8% 5d) with bearish MACD, trend may be turning.
2. Insider selling cluster: $3.7M in recent transactions.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.50 elevated, pricing in significant growth expectations. Forward P/E 14.5x stretched relative to 7% growth. Quality metrics strong (ROA 10%). Balance sheet: strong liquidity (2.4x), low leverage (D/E 0.35), $1.2B free cash flow. Analyst sentiment positive (1 raises, avg +5%). Insider selling cluster ($3.7M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $39.7B |
| Beta | 0.97 |
| 52W Range | $65.15 - $90.82 |
| Short Interest | 7.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.50 |
| Forward P/E | 14.5 |
| Current P/E | 15.5 |
| YoY Growth | 7.0% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -0.3% to -3.1% (-2.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.1pp (needs >3.0% for momentum thesis). Underperforming sector by 3.2pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.09x) but short-term weakness (below SMA20). MACD histogram bearish (-0.65), momentum weakening. RSI neutral at 49. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -3.06% (CS: 7) | Weak |
| RSI_14 | 48.7 | Neutral |
| MACD Histogram | -0.65 | Bearish |
| vs SMA20 | 0.974x | Below |
| vs SMA50 | 1.052x | Above |
| vs SMA200 | 1.088x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $81.28
- **Stop Loss:** $78.10 (3.9% risk)
- **Target:** $84.46 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 377
- **Position Value:** $30,642.56
- **Portfolio %:** 30.64%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-02-04 (Est: $1.32)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.30 | $1.39 | +6.7% |
| 2025Q2 | $1.26 | $1.31 | +4.0% |
| 2025Q1 | $1.20 | $1.23 | +2.5% |
| 2024Q4 | $1.13 | $1.21 | +7.6% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_10*